OSI trying drug on early lung cancer
Hoping to beat back lung cancer, researchers at OSI Pharmaceuticals Inc. in Melville plan to study how the company’s Tarceva pill might be used to recast the disease as chronic but manageable in some patients.
This entry was posted on Friday, September 29th, 2006 at 9:42 pm and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.